Jun 2026 (Q2 FY26) — Aug 11, 2026
Spectral AI Q2 FY26 — DeepView FDA Clearance and Commercialization Focus
Read the full callSpectral AI (MDAI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Spectral AI earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 3.5 | −30.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -122.7 | −80.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -4.2 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$1.52 +0.66% · +$0.01
Performance −36.4% 1Y
1Y: $2.39 on 17 Oct 2025 → $1.52. High $2.68 (22 May 2026), low $1.2 (18 Mar 2026).
- Previous close
- $1.51
- 52-week range
- $1.2 – $2.68
- One year
- −41.09%
Overview
- Symbol
- MDAI
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Spectral AI earnings calls (MDAI)
Financials
What the filings say
Net profit, year on year: +48% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 8 | 8 | 7 | 5 | 4 | 4 | 4 | 4 |
| Operating profit | -1 | -1 | -1 | -2 | -3 | -2 | -2 | -4 |
| Operating margin | −10.8% | −14.6% | −13.4% | −41.9% | −88.1% | −54.9% | −49.4% | −122.7% |
| Other income | -1 | -6 | 4 | -6 | -0 | 3 | -1 | 0 |
| Interest | 0 | — | 0 | 0 | 0 | — | 0 | 0 |
| Profit before tax | -1 | -8 | 3 | -8 | -4 | 1 | -3 | -4 |
| Tax rate | −2.5% | −1.9% | 2.4% | 0.2% | −0.1% | −4.3% | 0.3% | −4.2% |
| Net profit | -2 | -8 | 3 | -8 | -4 | 1 | -3 | -4 |
| EPS ($ per share) | -0.08 | — | 0.13 | -0.31 | -0.13 | — | -0.11 | -0.13 |
| Line item | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 |
| Reserves | -21 | -12 | -33 | -48 | -56 |
| Total liabilities | 22 | 7 | 12 | 19 | 27 |
| Fixed assets | — | 0 | 0 | 0 | 0 |
| Total assets | 254 | 19 | 11 | 12 | 21 |
| Line item | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash from operations | -1 | -1 | -13 | -9 | -10 |
| Cash from investing | -253 | 252 | — | — | — |
| Cash from financing | 255 | -1 | 4 | 10 | 20 |
| Net cash flow | 1 | -2 | -9 | 0 | 10 |
Insider filings
24 filings between Mar 27, 2026 and Sep 28, 2026.
Open market
decisions to buy or sellNobody bought or sold MDAI on the open market in this window. The filings below are 24 awards.
Compensation
not trading decisions- 24
- Award — granted as compensation
Latest filings (30)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 28, 2026 | DiMaio John Michael Director | Award | 32,000 | $51.8K |
| Sep 23, 2026 | DiMaio John Michael Director | Award | 60,000 | $100.2K |
| Sep 21, 2026 | DiMaio John Michael Director | Award | 21,012 | $35.5K |
| Sep 18, 2026 | DiMaio John Michael Director | Award | 10,988 | $17.7K |
| Sep 11, 2026 | DiMaio John Michael Director | Award | 22,000 | $35.0K |
| Sep 10, 2026 | DiMaio John Michael Director | Award | 10,000 | $15.6K |
| Aug 13, 2026 | DiMaio John Michael Director | Award | 35,000 | $57.4K |
| Jun 29, 2026 | DiMaio John Michael Director | Award | 15,000 | $25.9K |
| Jun 25, 2026 | DiMaio John Michael Director | Award | 14,700 | $24.8K |
| Jun 24, 2026 | DiMaio John Michael Director | Award | 14,300 | $24.9K |
| May 29, 2026 | DiMaio John Michael Director | Award | 15,000 | $31.8K |
| May 28, 2026 | DiMaio John Michael Director | Award | 2,500 | $5.9K |
| May 26, 2026 | DiMaio John Michael Director | Award | 32,233 | $84.1K |
| May 18, 2026 | Cotton Richard John Director | Award | 8,818 | $21.2K |
| May 15, 2026 | Cotton Richard John Director | Award | 5,882 | $13.7K |
| May 15, 2026 | DiMaio John Michael Director | Award | 25,000 | $54.0K |
| May 15, 2026 | DiMaio John Michael Director | Award | 1,887 | $4.0K |
| Apr 24, 2026 | Sadagopan Deepak Director | Award | 25,000 | $0 |
| Apr 24, 2026 | Capone Vincent S. Chief Executive Officer | Award | 100,000 | $0 |
| Apr 24, 2026 | Snyder Marion Ann Director | Award | 25,000 | $0 |
| Apr 24, 2026 | Cotton Richard John Director | Award | 29,850 | $0 |
| Apr 24, 2026 | DiMaio John Michael Director | Award | 100,000 | $0 |
| Mar 27, 2026 | DiMaio John Michael Director | Award | 7,619 | $12.0K |
| Mar 27, 2026 | Capone Vincent S. Chief Executive Officer | Award | 16,750 | $25.5K |
| Jun 10, 2025 | DiMaio John Michael Director | Award | 9,700 | $20.5K |
| Jun 9, 2025 | DiMaio John Michael Director | Award | 2,000 | $4.2K |
| Jun 4, 2025 | Mellish Martin C.B. Director | Award | 5,000 | $8.7K |
| Apr 30, 2025 | Cotton Richard John Director | Award | 9,699 | $0 |
| Apr 30, 2025 | Mellish Martin C.B. Director | Award | 9,699 | $0 |
| Apr 30, 2025 | Capone Vincent S. CFO and General Counsel | Award | 100,000 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Spectral AI, Inc.
Free account. Everything above stays public.
Write why you follow Spectral AI, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading